Literature DB >> 11715001

Phenotype and genotype variation in primary carnitine deficiency.

Y Wang1, S H Korman, J Ye, J J Gargus, A Gutman, F Taroni, B Garavaglia, N Longo.   

Abstract

PURPOSE: Primary carnitine deficiency is an autosomal recessive disorder of fatty acid oxidation resulting from defective carnitine transport. This disease is caused by mutations in the carnitine transporter gene SLC22A5. The objective of this study was to extend mutational analysis to four additional families with this disorder and determine whether recurrent mutations could be found.
METHODS: The SLC22A5 gene encoding the OCTN2 carnitine transporter was sequenced, and the missense mutations identified were expressed in Chinese hamster ovary (CHO) cells.
RESULTS: DNA sequencing revealed four novel mutations (Y4X; dup 254-264, 133X; R19P; R399Q). Alleles introducing premature STOP codons reduced the levels of OCTN2 mRNA. Carnitine transport in CHO cells expressing the R19P and R399Q mutations was reduced to < 5% of normal. The 133X mutation was found in two unrelated European families. Two patients within the same family, both homozygous for the same mutation (R399Q) had completely different clinical presentation.
CONCLUSIONS: Heterogeneous mutations in the SLC22A5 gene cause primary carnitine deficiency. Different presentations are observed even in children with identical mutations.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11715001     DOI: 10.1097/00125817-200111000-00002

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  22 in total

Review 1.  Pharmacogenomics and systems biology of membrane transporters.

Authors:  Qing Yan
Journal:  Mol Biotechnol       Date:  2005-01       Impact factor: 2.695

Review 2.  Lipid storage myopathy.

Authors:  Wen-Chen Liang; Ichizo Nishino
Journal:  Curr Neurol Neurosci Rep       Date:  2011-02       Impact factor: 5.081

3.  Identification of mutations and evaluation of cardiomyopathy in Turkish patients with primary carnitine deficiency.

Authors:  M Kilic; R K Ozgül; T Coşkun; D Yücel; M Karaca; H S Sivri; A Tokatli; M Sahin; T Karagöz; A Dursun
Journal:  JIMD Rep       Date:  2011-09-22

4.  Functional and molecular studies in primary carnitine deficiency.

Authors:  Marta Frigeni; Bijina Balakrishnan; Xue Yin; Fernanda R O Calderon; Rong Mao; Marzia Pasquali; Nicola Longo
Journal:  Hum Mutat       Date:  2017-09-14       Impact factor: 4.878

Review 5.  Brain carnitine deficiency causes nonsyndromic autism with an extreme male bias: A hypothesis.

Authors:  Arthur L Beaudet
Journal:  Bioessays       Date:  2017-07-13       Impact factor: 4.345

6.  Genotype-phenotype correlation in primary carnitine deficiency.

Authors:  Emily C Rose; Cristina Amat di San Filippo; Uzochi C Ndukwe Erlingsson; Orly Ardon; Marzia Pasquali; Nicola Longo
Journal:  Hum Mutat       Date:  2011-10-11       Impact factor: 4.878

Review 7.  Disorders of carnitine transport and the carnitine cycle.

Authors:  Nicola Longo; Cristina Amat di San Filippo; Marzia Pasquali
Journal:  Am J Med Genet C Semin Med Genet       Date:  2006-05-15       Impact factor: 3.908

8.  Relative carnitine deficiency in autism.

Authors:  Pauline A Filipek; Jenifer Juranek; Minh T Nguyen; Christa Cummings; J Jay Gargus
Journal:  J Autism Dev Disord       Date:  2004-12

Review 9.  Inborn errors of energy metabolism associated with myopathies.

Authors:  Anibh M Das; Ulrike Steuerwald; Sabine Illsinger
Journal:  J Biomed Biotechnol       Date:  2010-05-26

10.  Cardiomyopathy and carnitine deficiency.

Authors:  Cristina Amat di San Filippo; Matthew R G Taylor; Luisa Mestroni; Lorenzo D Botto; Nicola Longo
Journal:  Mol Genet Metab       Date:  2008-03-11       Impact factor: 4.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.